BackNeuBase Therapeutics Overview

NeuBase Therapeutics Cost of Revenue

Cost of Revenue analysis for NBSE.

Quarterly Cost of Revenue

$250246.00
↓ 25.4% YoY

As of Sep 30, 2023

Annual Cost of Revenue (TTM)

$854694.00
↓ 32.3% YoY

Trailing 12 months ending Sep 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin